Institute for International Research

"New information regarding immunogenicity testing"
-Lynne LeSauteur, Scientific Director, CHARLES RIVER LABORATORIES

"To learn what others are doing, and to learn new approaches to dealing with drug in samples"
-Deborah Finco-Kent, Senior Scientist, PFIZER

What did you like best about Immunogenicity for Biotherapeutics 2006?

"Learning what other companies are doing in this field and the sharing of information"
- Cindy Pauley, Senior Research Associate, MERCK and CO.

"Sessions that provide case studies and useful applications--of which most presentations did. This was the best conference yet (with respect to presenting data and case studies)"
-Deborah Finco-Kent, Senior Scientist, PFIZER

"It's a very focused group. Everybody has the same concerns and similar experience, which can be shared among others."
- Xing Li, Senior Scientist, VIRON